Amarin Corp Plc (AMRN)

[Pharmacydude]

Kiwi
I have a bit of a bias against MITIGATE. If Kaiser really wanted to “help” or do the best thing for their pts then the 15,000 control pts WITH KNOWN CVD would already be on V. Kaiser could very easily crunch their existing data of all V pts and all equivalent pts and compare COVID results over the past year and already know the answer. The sceptic in me fears that Kaiser only set up this trial to get 1500 patients on free Vascepa with Amarin supplying the trial drug.
If you recall in The Widowmaker documentary Kaiser was singled out for refusing to pay for CAC’s because they calculated that their clients only stay with them for an average of 5 years so it wasn’t worth it financially to pay for preventative therapies because some other insurance company would benefit from their investment. Look at all the trouble you had to go through to get V covered even after R-it. I don’t trust insurance companies period. They are there to make a profit not to do the best thing for their Pt. It’s a business, nothing more. Make a profit at any cost. Sure, ICER said it was cost effective IN THE LONG TERM to put pts on V but Kaiser only looks at this quarter’s profit and minimizing expenses (eg denying coverage).